Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation

BACKGROUND: The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity early after renal transplantation. PTDM diagnosed with an oral glucose tolerance...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Nephrol
Päätekijät: Ussif, Amin M., Åsberg, Anders, Halden, Thea Anine Strøm, Nordheim, Espen, Hartmann, Anders, Jenssen, Trond
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327477/
https://ncbi.nlm.nih.gov/pubmed/30630438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-1171-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia